Sep 26, 2017 20:05 pm UTC| Business
NEW YORK, Sept. 26, 2017 -- At the end of the settlement date of September 15, 2017, short interest in 2,341 Nasdaq Global MarketSM securities totaled 7,668,720,475 shares compared with 7,585,840,717 shares in 2,347...
Lam Research Corporation Announces September Quarter Financial Conference Call
Sep 26, 2017 20:05 pm UTC| Business
FREMONT, Calif., Sept. 26, 2017 -- Lam Research Corporation (Nasdaq:LRCX) today announced that the company will host its quarterly financial conference call and webcast on Tuesday, October 17, beginning at 2:00 p.m....
ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer
Sep 26, 2017 20:05 pm UTC| Business
DOYLESTOWN, Pa., Sept. 26, 2017 -- ProPhase Labs, Inc. (NASDAQ:PRPH) (www.ProPhaseLabs.com), a diversified natural health medical science company (“ProPhase”), announced today the preliminary results of its tender offer...
Global Blood Therapeutics Announces New Employment Inducement Grants
Sep 26, 2017 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that on September 25, 2017, the compensation committee of the Company’s board of directors granted one...
Werner Enterprises Announces Upcoming Release of Third Quarter 2017 Earnings
Sep 26, 2017 20:05 pm UTC| Business
OMAHA, Neb., Sept. 26, 2017 -- Werner Enterprises, Inc. (NASDAQ:WERN), one of the nation’s largest transportation and logistics companies, announced today that it will release its third quarter 2017 earnings on...
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Sep 26, 2017 20:01 pm UTC| Business
NEW YORK, Sept. 26, 2017 -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company, today announced that it has commenced an underwritten public offering of $150 million of shares of its common stock....
Sep 26, 2017 20:01 pm UTC| Business
REDWOOD CITY, Calif., Sept. 26, 2017 -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for Peripheral Artery Disease (PAD), today announced Conformité Européenne (CE) Marking approval for...